Table 2.
Univariate analysis of END or HT in patients with elevated or normal hs‐cTnT levels
| Variable | hs‐cTnT >14 ng/L (n = 65) | hs‐cTnT ≤14 ng/L (n = 176) | P‐value | OR (95% CI) |
|---|---|---|---|---|
| Early neurological deterioration, n (%) | 3 (4.6) | 8 (4.5) | .982 | 1.016 (0.261, 3.953) |
| Hemorrhagic transformation, n (%) | 9 (13.8) | 13 (7.4) | .128 | 2.015 (0.817, 4.969) |
| Symptomatic ICH, n (%) | 3 (4.6) | 5 (2.8) | .499 | 1.655 (0.384, 7.130) |
| Asymptomatic ICH, n (%) | 6 (9.2) | 8 (4.5) | .176 | 2.136 (0.711, 6.411) |
| Hemorrhagic transformation types | ||||
| HI‐1 (hemorrhagic infarction‐1), n (%) | 1 (11.1) | 2 (15.4) | .190 | |
| HI‐2 (hemorrhagic infarction‐2), n (%) | 1 (11.1) | 3 (23.1) | ||
| PH‐1 (parenchymal Hemorrhage‐1), n (%) | 3 (33.3) | 0 | ||
| PH‐2 (parenchymal Hemorrhage‐2), n (%) | 4 (44.4) | 8 (61.5) | ||
| Remote parenchymal hemorrhage, n (%) | 2 (3.1) | 3 (1.7) | .513 | 1.831 (0.299, 11.21) |
Abbreviations: END, early neurological deterioration; HT, hemorrhagic transformation; hs‐cTnT, high‐sensitivity cardiac troponin T; ICH, intracerebral hemorrhage.